Nurami Medical finishes recruitment for tissue damage clinical trial
Thursday, 03 Feb 2022
Nurami Medical has recruited all the patients for a clinical trial on its product, ArtiFascia, a synthetic implant for restoring and repairing membranes after surgical procedures